Geode Capital Management, LLC Bio Affinity Technologies, Inc. Transaction History
Geode Capital Management, LLC
- $1.21 Trillion
- Q3 2024
A detailed history of Geode Capital Management, LLC transactions in Bio Affinity Technologies, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 87,181 shares of BIAF stock, worth $82,821. This represents 0.0% of its overall portfolio holdings.
Number of Shares
87,181
Previous 69,600
25.26%
Holding current value
$82,821
Previous $150,000
20.67%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding BIAF
# of Institutions
15Shares Held
468KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA261KShares$247,8250.0% of portfolio
-
Captrust Financial Advisors Raleigh, NC27.9KShares$26,4900.0% of portfolio
-
Sheaff Brock Investment Advisors, LLC20KShares$19,0000.0% of portfolio
-
State Street Corp Boston, MA17.6KShares$16,7200.0% of portfolio
-
Northern Trust Corp Chicago, IL13.7KShares$12,9780.0% of portfolio
About bioAffinity Technologies, Inc.
- Ticker BIAF
- Exchange
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 2,727,580
- Market Cap $2.59M
- Description
- bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is b...